You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-bulky

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)

Terminated
  • Non-small Cell Lung Cancer
  • chest radiation
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 25, 2022

Hodgkin Lymphoma, Adult Trial in United States (Brentuximab vedotin, ABVD)

Completed
Has Results
  • Hodgkin Lymphoma, Adult
  • Brentuximab vedotin
  • ABVD
  • Duarte, California
  • +5 more
Nov 8, 2021

Follicular Lymphoma Trial in Newnan (Oncoquest-L vaccine)

Not yet recruiting
  • Follicular Lymphoma
  • Oncoquest-L vaccine
  • Newnan, Georgia
    Southeastern Regional Medical Center at CTCA
Apr 7, 2021

Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

Recruiting
  • Large B-cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • Comprehensive Ablative Bridging Irradiation (CABI)
  • Chimeric Antigen Receptor T-Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
Oct 26, 2023

Bystander Effect, Abscopal Effect, Unresectable Malignant Solid Tumor Trial in Klagenfurt (SBRT-PATHY (SBRT-based PArtial Tumor

Recruiting
  • Bystander Effect
  • +3 more
  • SBRT-PATHY (SBRT-based PArtial Tumor irradiation targeting HYpoxic segment)
  • Klagenfurt, Kaernten, Austria
    KABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Apr 6, 2022

NSCLC Trial in Guangzhou (Concurrent chemo, split-course radiotherapy, thymosin alpha 1)

Completed
  • Non-small Cell Lung Cancer
  • Concurrent chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Dec 30, 2021

Hodgkin Lymphoma Trial in Boston (Brentuximab Vedotin, Adriamycin, Dacarbazine)

Completed
Has Results
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 10, 2020

Lymphoma Trial in United States (biological, drug, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +7 more
  • Anchorage, Alaska
  • +47 more
Dec 22, 2021

Hodgkin Lymphoma Trial in Italy, Poland, Spain (Nivolumab 10 MG/ML)

Recruiting
  • Hodgkin Lymphoma
  • Nivolumab 10 MG/ML
  • Pavia, P.le Golgi 19, Italy
  • +26 more
Aug 11, 2021

Cancer Trial in Wiener Neustadt (Particle radiotherapy, Magnetic resonance imaging, Computertomography)

Recruiting
  • Cancer
  • Particle radiotherapy
  • +5 more
  • Wiener Neustadt, Niederösterreich, Austria
    EBG MedAustron GmbH
Dec 1, 2022

Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 20, 2023

HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)

Active, not recruiting
  • HPV-Related Squamous Cell Carcinoma
  • HNSCC
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021

Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil

Completed
  • Gynecologic Cancer
  • Laparoscopic ultra-radical lymph node debulking
  • Palermo, Sicily, Italy
    University of Palermo
Jul 13, 2022

Bladder Cancer Trial in Dallas (personalized ultrafractionated stereotactic ablative radiotherapy)

Recruiting
  • Bladder Cancer
  • personalized ultrafractionated stereotactic ablative radiotherapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Feb 24, 2022

Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)

Not yet recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • +5 more
  • Upfront resection
  • (no location specified)
Nov 9, 2022

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Metastatic Colorectal Cancer Trial in Madison (Panitumumab, Cetuximab, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 13, 2022

Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

Active, not recruiting
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +5 more
  • Fountain Valley, California
  • +75 more
Dec 2, 2022

Malignant Tumors Trial in China, United States (SCART radiation therapy)

Not yet recruiting
  • Malignant Neoplasms
  • SCART radiation therapy
  • Miami, Florida
  • +3 more
May 6, 2021

Lymphoma Trial in Australia, New Zealand, United Kingdom (rituximab, No treatment)

Active, not recruiting
  • Lymphoma
  • rituximab
  • No treatment
  • Adelaide, Australia
  • +71 more
Nov 3, 2020

Hodgkin Lymphoma Trial in Jacksonville (Proton Radiation Plan, Conventional Photon Radiation Plan, Intensity Modulated Radiation

Completed
Has Results
  • Hodgkin Lymphoma
  • Proton Radiation Plan
  • +2 more
  • Jacksonville, Florida
    University of Florida Proton Therapy Institute
Jan 8, 2019

Carpal Tunnel Syndrome Trial (Bandaid, Conventional bulky soft tissue dressing)

Not yet recruiting
  • Carpal Tunnel Syndrome
  • Bandaid
  • Conventional bulky soft tissue dressing
  • (no location specified)
Aug 13, 2021

Lymphoma Trial in United States (ABVD, BEACOPP, radiation therapy)

Completed
Has Results
  • Lymphoma
  • Saint Helena, California
  • +54 more
Nov 5, 2021

LiDCOrapid in Resuscitation of Critically Ill Septic Shock: A

Completed
  • Cardiac Output, LIDCO Rapid, Septic Shock
  • fluid resuscitation with crystalloid
  • Cairo, Egypt
    Kasr El Ainy Shcool of Medicine
Aug 12, 2021